CIRM's 2018 Annual Report sums up the agency accomplishments over the last year in just 24 pages, The report look at the highlights, progress, and the impact CIRM has had on stem cell research over the last year. But it’s also a look forward at the challenges ahead and the people who will help us … Continue reading CIRM’s 2018 Annual Report
Rich Lajara
Stem Cell Agency celebrates 50 clinical trials with patient #1
Yesterday the CIRM Board approved funding for our 50th clinical trial (you can read about that here) It was an historic moment for us and to celebrate we decided to go back in history and hear from the very first person to be treated in a CIRM-funded clinical trial. Rich Lajara was treated in the … Continue reading Stem Cell Agency celebrates 50 clinical trials with patient #1
Stem Cell Agency Board Approves 50th Clinical Trial
May 4th, 2011 marked a landmark moment for the California Institute for Regenerative Medicine (CIRM). On that day the Stem Cell Agency’s Board voted to invest in its first ever clinical trial, which was also the first clinical trial to use cells derived from embryonic stem cells. Today the Stem Cell Agency reached another landmark, … Continue reading Stem Cell Agency Board Approves 50th Clinical Trial